Daniel R. Chevallard

CIK: 0001706176

Transaction Breakdown

Open Market Buys (P)3 (42.9%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LENZ

LENZ Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

LENZ
LENZ Therapeutics, Inc.
Oct 30, 2026
Award(A)
Stock Option (right to buy)
Direct
652.1K shares-
LENZ
LENZ Therapeutics, Inc.
Mar 27, 2026
Purchase(P)
Direct
7.5K shares at avg. $8.57$64K
LENZ
LENZ Therapeutics, Inc.
Jan 2, 2026
Award(A)
Stock Option (right to buy)
Direct
84.2K shares-
LENZ
LENZ Therapeutics, Inc.
Jan 2, 2026
Award(A)
Restricted Stock Unit
Direct
14K shares-
LENZ
LENZ Therapeutics, Inc.
Nov 7, 2025
Purchase(P)
Direct
2.2K shares at avg. $22.76$50K
LENZ
LENZ Therapeutics, Inc.
Nov 7, 2025
Purchase(P)
Direct
20 shares at avg. $22.71$454.2
LENZ
LENZ Therapeutics, Inc.
Jan 9, 2025
Award(A)
Stock Option (right to buy)
Direct
70.4K shares-

		Type	Shares	Price		Ownership
Oct 30, 2026	LENZ LENZ Therapeutics, Inc.	Award(A) Stock Option (right to buy)	652,063	-	-	Direct
Mar 27, 2026	LENZ LENZ Therapeutics, Inc.	Purchase(P)	7,500	$8.57	$64,275	Direct
Jan 2, 2026	LENZ LENZ Therapeutics, Inc.	Award(A) Stock Option (right to buy)	84,200	-	-	Direct
Jan 2, 2026	LENZ LENZ Therapeutics, Inc.	Award(A) Restricted Stock Unit	14,000	-	-	Direct
Nov 7, 2025	LENZ LENZ Therapeutics, Inc.	Purchase(P)	2,178	$22.76	$49,563	Direct
Nov 7, 2025	LENZ LENZ Therapeutics, Inc.	Purchase(P)	20	$22.71	$454	Direct
Jan 9, 2025	LENZ LENZ Therapeutics, Inc.	Award(A) Stock Option (right to buy)	70,444	-	-	Direct

1-7 of 7 transactions

About Chevallard Daniel R.

Chevallard Daniel R. (SEC CIK 0001706176) files insider reports with the SEC as Chief Financial Officer of LENZ Therapeutics, Inc. (LENZ).

Signal8 holds 5 ownership filings by Chevallard Daniel R., all Form 4s, filed between Jan 13, 2025 and Nov 3, 2026. Those filings report 7 transactions, from Jan 9, 2025 to Oct 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chevallard Daniel R.'s filings is in SOLANA BEACH, CA.

Recent filings by Chevallard Daniel R.

Oct 30, 2026: Grant or award of LENZ derivative securities (Form 4, code A).
Mar 27, 2026: Open-market purchase of LENZ shares (Form 4, code P).
Jan 2, 2026: Grants or awards of LENZ derivative securities (2 lines, Form 4, code A).
Nov 7, 2025: Open-market purchases of LENZ shares (2 lines, Form 4, code P).
Jan 9, 2025: Grant or award of LENZ derivative securities (Form 4, code A).

Other insiders filing for LENZ Therapeutics, Inc. (LENZ)

How to read Form 4 transaction codes